ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $52,147 | -98.3% | 48,000 | -98.4% | 0.00% | -100.0% |
Q3 2020 | $3,065,000 | -9.2% | 2,935,000 | -3.8% | 0.03% | -15.0% |
Q2 2020 | $3,377,000 | -14.3% | 3,051,000 | -20.9% | 0.04% | -9.1% |
Q1 2020 | $3,942,000 | +1278.3% | 3,859,000 | +1431.3% | 0.04% | +2100.0% |
Q4 2019 | $286,000 | -87.9% | 252,000 | -87.8% | 0.00% | -88.9% |
Q3 2019 | $2,361,000 | -55.1% | 2,069,000 | -53.3% | 0.02% | -52.6% |
Q2 2019 | $5,264,000 | +79.9% | 4,427,000 | +104.7% | 0.04% | +58.3% |
Q1 2019 | $2,926,000 | +85.9% | 2,163,000 | +45.7% | 0.02% | +140.0% |
Q3 2018 | $1,574,000 | -46.5% | 1,485,000 | -50.5% | 0.01% | -37.5% |
Q2 2018 | $2,943,000 | +506.8% | 3,003,000 | +512.9% | 0.02% | +433.3% |
Q1 2018 | $485,000 | -76.4% | 490,000 | -75.6% | 0.00% | -72.7% |
Q4 2016 | $2,051,000 | +196.4% | 2,012,000 | +106.4% | 0.01% | +266.7% |
Q2 2016 | $692,000 | -25.1% | 975,000 | +18.8% | 0.00% | -40.0% |
Q4 2015 | $924,000 | – | 821,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |